OpenURL Connection Search

Select item for more details and to access through your institution.

The Israel National Brain Repository.The establishment and uniqueness of the first brain bank in Israel.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.079606
By:
- Manzali, Sigalit;
- Ravona‐Springer, Ramit;
- Heymann, Anthony;
- Greenbaum, Lior;
- Cooper, Itzik;
- Gardner, Raquel C.;
- Liraz‐Zaltsman, Sigal;
- Beeri, Michal S
Publication type:
Article
Blood DNA methylation biomarkers for cognitive decline in older adults with type 2 diabetes.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065120
By:
- Manzali, Sigalit;
- Ravona‐Springer, Ramit;
- Jacob‐Hirsch, Jasmine;
- Heymann, Anthony;
- Beeri, Michal Schnaider;
- Greenbaum, Lior
Publication type:
Article
The National Israel Brain Repository: Characterizing those who sign and do not sign intent to autopsy.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064443
By:
- Manzali, Sigalit;
- Ravona‐Springer, Ramit;
- Ouyang, Yuxia;
- Lin, Hung‐Mo;
- Heymann, Anthony;
- Greenbaum, Lior;
- Liraz‐Zaltsman, Sigal;
- Beeri, Michal Schnaider
Publication type:
Article
No evidence for association of Alzheimer's disease risk loci with the rate of cognitive decline among elderly with type 2 diabetes.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.050081
By:
- Greenbaum, Lior;
- Manzali, Sigalit;
- Ravona‐Springer, Ramit;
- Lin, HungMo;
- Beeri, Michal Schnaider
Publication type:
Article
The COMT rs4680 polymorphism is associated with rate of cognitive decline in older adults with type 2 diabetes: Biomarkers (non‐neuroimaging) / Longitudinal change over time.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045227
By:
- Manzali, Sigalit;
- Beeri, Michal Schnaider;
- Ravona‐Springer, Ramit;
- Lin, HungMo;
- Liu, Xiaoyu;
- Heymann, Anthony;
- Greenbaum, Lior
Publication type:
Article
Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.
Published in:
Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.853695
By:
- Manzali, Sigalit B.;
- Yu, Eric;
- Ravona-Springer, Ramit;
- Livny, Abigail;
- Golan, Sapir;
- Ouyang, Yuxia;
- Lesman-Segev, Orit;
- Lang Liu;
- Ganmore, Ithamar;
- Alkelai, Anna;
- Gan-Or, Ziv;
- Hung-Mo Lin;
- Heymann, Anthony;
- Schnaider Beeri, Michal;
- Greenbaum, Lior
Publication type:
Article
Long‐term trajectories and current BMI are associated with poorer cognitive functioning in middle‐aged adults at high Alzheimer's disease risk.
Published in:
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12247
By:
- West, Rebecca K.;
- Ravona‐Springer, Ramit;
- Sharvit‐Ginon, Inbal;
- Ganmore, Ithamar;
- Manzali, Sigalit;
- Tirosh, Amir;
- Golan, Sapir;
- Boccara, Ethel;
- Heymann, Anthony;
- Beeri, Michal Schnaider
Publication type:
Article

Found: 7

The Israel National Brain Repository.The establishment and uniqueness of the first brain bank in Israel.

Blood DNA methylation biomarkers for cognitive decline in older adults with type 2 diabetes.

The National Israel Brain Repository: Characterizing those who sign and do not sign intent to autopsy.

No evidence for association of Alzheimer's disease risk loci with the rate of cognitive decline among elderly with type 2 diabetes.

The COMT rs4680 polymorphism is associated with rate of cognitive decline in older adults with type 2 diabetes: Biomarkers (non‐neuroimaging) / Longitudinal change over time.

Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.

Long‐term trajectories and current BMI are associated with poorer cognitive functioning in middle‐aged adults at high Alzheimer's disease risk.